Neonatal abstinence scores in opioid-exposed and nonexposed neonates: A blinded comparison

Journal of Opioid Management

Volumn 6, Issue 6, 2010, Pages 409-413

  Jones, Hendrée E ^a   Harrow, Cheryl ^b   O'Grady, Kevin E ^c   Crocetti, Michael ^a   Jansson, Lauren M ^a   Kaltenbach, Karol ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Methadone; Neonate; Pregnancy; Substance abuse; Women

Indexed keywords

ALCOHOL; COCAINE; OPIATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DRUG EXPOSURE; FEMALE; HUMAN; HYPERREFLEXIA; MUSCLE TONE; NEWBORN; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY ANALYSIS; TREMOR; WITHDRAWAL SYNDROME;

ADULT; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY;

EID: 79551559167     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2010.0038     Document Type: Article

References (19)

1. Substance Abuse and Mental Health Services Administration. Office of Applied Studies: Results from the 2007 national survey on drug use and health: National findings, Rep. No. NSDUH Series H-34, DHHS Publication No SMA 08-4343. 2008.
2. Kaltenbach K, Finnegan LP: Methadone maintenance during pregnancy: Implications for perinatal and developmental outcome. In Sonderegger T (ed.): Perinatal Substance Abuse: Research Findings and Clinical Implications. Baltimore MD: John Hopkins University Press, 1990: 239-253.
3. Connaughton JF Jr, Finnegan LP, Schut J, et al.: Current concepts in the management of the pregnant opiate addict. Addict Dis. 1975; 2(1-2): 21-35.
4. Blinick G, Wallach RC, Jerez E: Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program. Am J Obstet Gynecol. 1969; 105(7): 997-1003.
5. Kandall SR, Gartner LM: Late presentation of drug withdrawal symptoms in newborns. Am J Dis Child. 1974; 127(1): 58-61.
6. Zahorodny W, Rom C, Whitney W, et al.: The neonatal withdrawal inventory: A simplified score of newborn withdrawal. J Behav Pediatr. 1998; 19(2): 89-93.
7. Green M, Suffet F: The neonatal narcotic withdrawal index: A device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse. 1981; 8(2): 203-213. (Pubitemid 12206354)
8. Lipsitz PJ: A proposed narcotic withdrawal score for use with newborn infants: A pragmatic evaluation of its efficacy. Clin Pediatr. 1975; 14(6): 592-594.
9. Finnegan LP, Kaltenbach K: Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al. (eds.): Primary Pediatric Care. 2nd ed. St. Louis: Mosby, 1992: 1367-1378.
10. O'Grady MJ, Hopewell J, White MJ: Management of neonatal abstinence syndrome: A national survey and review of practice. Arch Dis Child Fetal Neonatal Ed. 2009; 94(4): F249-F252.
11. Jansson LM, Velez M, Harrow C: The opioid-exposed newborn: Assessment and pharmacologic management. J Opioid Manag. 2009; 5(1): 47-55.
12. Jones HE, Johnson RE, Jasinski DR, et al.: Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005; 79(1): 1-10.
13. Choo RE, Huestis MA, Schroeder JR, et al.: Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004; 75(3): 253-260.
14. Fischer G, Ortner R, Rohrmeister K, et al.: Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction. 2006; 101(2): 275-281.
15. Winklbaur B, Baewert A, Jagsch R, et al.: Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res. 2009; 15(3): 150-156.
16. Jansson LM, DiPietro JA, Elko A, et al.: Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med. 2007; 20(9): 677-685. (Pubitemid 47262703)
17. Jansson LM, DiPietro JA, Elko A, et al.: Infant autonomic functioning and neonatal abstinence syndrome. Drug Alcohol Depend. 2010; 109(1-3): 198-204.
18. Jansson LM, Velez ML: Infants of drug-dependent mothers. Pediatr Rev. (in press).
19. Franck LS, Harris SK, Soetenga DJ, et al.: The Withdrawal Assessment Tool-Version 1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008; 9(6): 573-580.